ArticleOncoimmunology2022

One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer.

Jonas Steenbrugge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.